Super Bowl LIX champion Dallas Goedert of the Philadelphia Eagles shares his journey with plaque psoriasis. After 20 years of ...

A real-world study in Spain finds faster improvements with induction therapy but highlights long-term drug survival ...

Psoriasis, a chronic skin condition that causes inflammation in the form of raised plaques and scales on the body, affects more than 3% of the U.S. adult population. Symptoms often begin between ...

QX004N, an interleukin-23 inhibitor, showed safety and efficacy in the treatment of moderate to severe plaque psoriasis, according to a study. QX004N, an IL-23 inhibitor, showed safety and ...

Vyne Therapeutics has dosed the first participant in a randomised Phase Ib clinical trial of VYN202, an oral treatment for moderate-to-severe plaque psoriasis. The double-blind, placebo-controlled ...

That’s because certain genes play a role. Psoriasis is a skin disease that affects about 8 million Americans. It comes in several forms. Plaque psoriasis is the most common. Plaque psoriasis ...

Feb. 3, 2025 — Psoriasis is a chronic skin disease that manifests itself mainly with skin symptoms (dryness, itching, scaly skin, abnormal patches and plaques). It affects about 2% of the ...

Corticosteroid creams and ointments can stop the overproduction of skin cells that make psoriasis plaques, but makeup may not stick to skin that has a heavy cream or ointment on it. Consider using ...

It can be classified into a number of types according to appearance. The most common types include plaque psoriasis, which appears as thick scaly patches on the skin; erythrodemic psoriasis ...